BIOMAT Database Logo BIOMAT Database Logo

[Hepatotoxic syndrome caused by erythromycin ethyl succinate]. 1982

P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi

UI MeSH Term Description Entries
D008297 Male Males
D010612 Pharyngitis Inflammation of the throat (PHARYNX). Sore Throat,Pharyngitides,Sore Throats,Throat, Sore
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015643 Erythromycin Ethylsuccinate A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Monomycin,E-Mycin E,EryPed,Erythroped,Eyrthromycin Ethyl Succinate,Pediamycin,Wyamycin E,EMycin E,Ethyl Succinate, Eyrthromycin,Ethylsuccinate, Erythromycin,Succinate, Eyrthromycin Ethyl
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
Possible mild reaction to erythromycin ethyl succinate.
July 1979, The Journal of the Kansas Medical Society,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
Erythromycin ethyl succinate: diffusion through interstitial dermal fluid.
January 1987, European journal of clinical pharmacology,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
Use of erythromycin ethyl succinate in allergic children.
January 1969, Annals of allergy,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
[Use in pediatrics of a new form of erythromycin: erythromycin ethyl succinate].
March 1969, Journal de medecine de Lyon,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
[USE OF INJECTABLE ERYTHROMYCIN ETHYL SUCCINATE IN GENERAL SURGERY].
November 1964, Journal de medecine de Bordeaux et du Sud-Ouest,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
Influence of food on absorption of erythromycin ethyl succinate.
November 1980, Antimicrobial agents and chemotherapy,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
A CLINICAL STUDY OF ERYTHROMYCIN STEARATE AND ERYTHROMYCIN ETHYL SUCCINATE IN OFFICE PRACTICE.
September 1964, The Nebraska state medical journal,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
[Hepatotoxic syndrome of the colostatic type caused by josamycin].
October 1984, Minerva pediatrica,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
[Use of erythromycin ethyl succinate tablets for chewing, their value in dentistry].
November 1969, Le Chirurgien-dentiste de France,
P Cocchi, and M Silenzi, and G Salvi, and G Calabri, and M Tamburini, and P Alvisi
Comparison of serum erythromycin concentration following administration of 100 mg erythromycin ethyl succinate intramuscularly and 500 mg erythromycin stearate orally.
January 1981, International journal of oral surgery,
Copied contents to your clipboard!